Chemical Compound

Cefuracetime

CAS Registry Number 39685-31-9
Back to search Request a Quote
Cefuracetime chemical structure
Primary Record

Cefuracetime

In stock
4,124 g
Purity
98.2 %
CAS
39685-31-9

Compound Identifiers & Properties

CAS
39685-31-9
PubChem CID
9571078
SMILES
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CC=CO3)SC1)C(=O)O
Canonical SMILES
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1ccco1

Names & Synonyms

  • Cefuracetime
  • Cefuracetima
  • Cefuracetimum
  • DNP-beta-alanine
  • 39685-31-9
  • Cefuracetime [INN:BAN]
  • Cefuracetimum [INN-Latin]
  • Cefuracetima [INN-Spanish]
  • CEFURACETIME [INN]
  • RefChem:124269
  • Cefuracetime [BAN:INN]
  • Cefuroxime EP Impurity B
  • UNII-F69EA18270
  • Cefuracetimum (INN-Latin)
  • Cefuracetima (INN-Spanish)
  • C17H17N3O8S
  • Cefuroxime Sodium EP Impurity B
  • SCHEMBL615047
  • EINECS 254-592-2
  • SKF 81367
  • SKF-81367
  • orb1296238
  • CHEMBL2104152
  • F69EA18270
  • J01DA06
  • YBHZVPYSEUQIII-DYJQDLSISA-N
  • DTXSID901043307
  • PBA68531
  • SKF81367
  • C17-H17-N3-O8-S
  • HY-U00154
  • MFCD00865104
  • CID9571078
  • CS-7195
  • DA-51759
  • J91.947K
  • TS-10642
  • NS00011594
  • CEFUROXIME SODIUM IMPURITY B [EP IMPURITY]
  • 4-Pyridinylacetyl chloride hydrochloride (1:1)
  • G83672
  • A899656
  • CEFUROXIME SODIUM IMPURITY B (EP IMPURITY)
  • Q27277711
  • CEFUROXIME SODIUM EP IMPURITY B (REFERENCE GRADE)
  • (6R,7R)-3-Acetoxymethyl-7-((2Z)-2-(2-furyl)-2-methoxyiminoacetamido)-8-oxo-5-thia-1-azacyclo(4.2.0)oct-2-en-2carbonsaeure
  • 7-[2-(2-Furyl)-2-methoxyiminoacetamido]cephalosporanic acid
  • (6R,7R)-3-((ACETYLOXY)METHYL)-7-(((Z)-(FURAN-2-YL)(METHOXYIMINO)ACETYL)AMINO)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
  • (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((2-furanyl(methylimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
  • (7R)-7-(2-(2-Furyl)-2-((Z)-methoxyimino)acetylamino)cepham-3-ene-4-carboxylic acid
  • (7R)-7-[2-(2-Furyl)-2-[(Z)-methoxyimino]acetylamino]cepham-3-ene-4-carboxylic acid
  • (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-3-[(ACETYLOXY)METHYL]-7-[(2Z)-2-(FURAN-2-YL)-2-(METHOXYIMINO)ACETAMIDO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
  • (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
  • (7R)-3-(Acetyloxymethyl)-7-[[(Z)-(2-furanyl)(methoxyimino)acetyl]amino]cepham-3-ene-4-carboxylic acid
  • 254-592-2
  • 39685-78-4
  • Cefuroxime Sodium Imp. B (EP); (6R,7R)-7-[[(Z)-(Furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6a,7ss(Z)]]-; (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefuracetime; SKF 81367